Stay updated with breaking news from David Standaert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lixisenatide, a drug in the same family as Ozempic, seems to slow the progression of Parkinson’s disease. Plus, why scientists will look to the Sun’s corona during the 8 April eclipse. Lixisenatide, a drug in the same family as Ozempic, seems to slow the progression of Parkinson’s disease. Plus, why scientists will look to the Sun’s corona during the 8 April eclipse.
Diabetes drug lixisenatide could slow down progression of Parkinson's disease, a development that's considered a significance step in the disease's management. | Health
The booming class of GLP-1 drugs that includes Ozempic and Wegovy are showing potential to help conditions involving the brain.
The drug, which is in the same family as blockbuster weight-loss drugs such as Wegovy, slowed development of symptoms by a small but statistically significant amount. The drug, which is in the same family as blockbuster weight-loss drugs such as Wegovy, slowed development of symptoms by a small but statistically significant amount.
Phase II study of GLP-1 drug lixisenatide meets primary endpoint